Jubilant Life Sciences announced that CRISIL has assigned the following ratings to the company's facilities -
Long term rating for bank loan facilities (Rs 510 crore) - CRISIL AA (Placed on 'Rating Watch with Developing Implications')
Non-Convertible Debentures (Rs 350 crore) - CRISIL AA (Continues on 'Rating Watch with Developing Implications') (Rating withdrawn as NCDs have been fully redeemed)
Commercial Paper Programme (Rs 400 crore) - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
